OpenEvidence vs Triomics
Which Healthcare AI tool is better in 2026?
OpenEvidence
AI medical assistant for clinicians
Triomics
Oncology-specific AI agents that turn unstructured EHRs into structured cancer data
Side-by-side
OpenEvidence is the more established option (raised $735M); pricing is comparable on both sides.
| Metric | OpenEvidence | Triomics |
|---|---|---|
| Taglinei | AI medical assistant for clinicians | Oncology-specific AI agents that turn unstructured EHRs into structured cancer data |
| Foundedi | 2022 | 2021🏆 |
| HQi | San Francisco, US | San Francisco, US |
| Employeesi | 50-200🏆 | 11-50 |
| Neuron scorei | 64🏆 | 49 |
| Total fundingi | $735M🏆 | $36M |
| Latest roundi | Series D · Jan 2026 | Series B |
| Valuationi | $12B🏆 | — |
| Cheapest paid plani | — | Pricing not disclosed |
| Free plani | ✓ Free for Verified US Physicians | ✓ |
| Free triali | ✗ | ✓ |
| Top tier pricei | — | Pricing not disclosed |
| Pricing summaryi | 1 published plans | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for OpenEvidence and Triomics.
| Capability | OpenEvidence | Triomics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✓ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | 2 (TypeScript, Python) | — |
| Free plan | ✓ | ✓ |
| Free trial | ✗ | ✓ |
| Verified | ✓ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of OpenEvidence
- Has raised more capital ($735M vs $36M)
- Higher Neuron score (64 vs 49)
- Newer company (2022)
- Verified profile
🔵 Strengths of Triomics
- Offers a free trial
- More mature (2021)
Which should you choose?
Choose Triomics if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
OpenEvidence vs Triomics — which is better?
It depends on your priority. OpenEvidence has raised more capital and is the more established option; Triomics has broader feature depth. See the side-by-side table above.
Is OpenEvidence cheaper than Triomics?
No — Triomics's cheapest paid plan is Free, while OpenEvidence's is Free.
Do OpenEvidence and Triomics offer free plans?
OpenEvidence: Yes, has a free plan. Triomics: Yes, has a free plan.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.